Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CWBR | Common Stock | Purchase | $96.2K | +167K | +69.41% | $0.58* | 408K | Oct 28, 2021 | See Footnote | F1 |
Id | Content |
---|---|
F1 | The Reporting Person is a General Partner of V2M Life Sciences L.P. ("V2M"), and has sole voting and dispositive power over the securities held by V2M. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. |